Sotera Health Co (SHC) reported better-than-expected financial results for Q3 of fiscal 2025. The company posted earnings per share (EPS) of $0.26, surpassing Wall Street's consensus estimate of $0.22 by $0.04. Revenue matched expectations at $0.3 billion.
This update provides insight into Sotera Health's operational performance and financial health. The company, which specializes in mission-critical sterilization, lab testing, and advisory services for the medical device and pharmaceutical industries, continues to demonstrate robust fundamentals.
Sotera Health will host an earnings conference call at BMO to discuss these results and offer additional commentary on its business performance.
Investors should review the full earnings release for comprehensive context regarding the quarter's performance and future outlook. With a market cap of $4,454.59 million and a P/E ratio of 185.43, Sotera Health remains a key player in the life sciences tools and services sector. Upcoming earnings are scheduled for April 28, 2026, with an EPS estimate of $0.1719 and revenue forecast of $0.3 billion.